# Stoke Therapeutics, Inc. (STOK): MoatMap facts

As of 14 Nov 2026. Research data, not investment advice.

As of 14 Nov 2026, the MoatMap Score for Stoke Therapeutics, Inc. (STOK) is 9/100, ranked against 25,000+ stocks in 38 markets (Quality 30, Value 23, Momentum 29, each scored against its sector).

- MoatMap Score: 9/100, a percentile across 25,000+ stocks in 38 markets (100 is best).
- Quality 30, Value 23, Momentum 29: each a 0-100 percentile within Healthcare.
- Position: #24,170 overall, #2,308 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 26.68 USD on 13 Nov 2026.
- Insider filings, last 180 days: directors sold USD 1.6M.

Source: https://moatmap.ai/stock/STOK
How the scores work: https://moatmap.ai/methodology
Does the score work? Each tenth of the ranking is tracked monthly: https://moatmap.ai/decile-tracker
